Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial
Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference12%

- Check34 days agoChange DetectedThe page updates to a new version (v3.1.0) from v3.0.2, indicating a release upgrade. No other content changes are detailed here.SummaryDifference0.3%

- Check49 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.7%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.7%

- Check63 days agoChange DetectedThe web page has undergone significant changes with the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference8%

- Check77 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.